Annual report
6776.TEDINET S100YIYI
Period2025-04-01 → 2026-03-31
Filed2026-06-24
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥21.9bn | 2025-04-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥27.9bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥26.9bn | 2023-04-01 → 2024-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥23.9bn | 2022-04-01 → 2023-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥19.4bn | 2021-04-01 → 2022-03-31v | Cons. | Net sales (5-year summary) |
| Operating income | ¥723m | 2025-04-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | ¥914m | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥1.0bn | 2025-04-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.1bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.3bn | 2023-04-01 → 2024-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥752m | 2022-04-01 → 2023-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥355m | 2021-04-01 → 2022-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥745m | 2025-04-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.7bn | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥504m | 2025-04-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.3bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥948m | 2023-04-01 → 2024-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥612m | 2022-04-01 → 2023-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥246m | 2021-04-01 → 2022-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥504m | 2025-04-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | ¥1.4bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥21.0bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥22.1bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥28.0bn | at 2024-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥27.6bn | at 2023-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥21.3bn | at 2022-03-31v | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥10.0bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥11.5bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥11.0bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥10.6bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥10.9bn | at 2024-03-31v | Cons. | Net assets |
| Net assets / equity | ¥9.5bn | at 2023-03-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥8.1bn | at 2022-03-31v | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.2bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.3bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.2bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.3bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.3bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.6bn | at 2023-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥4.1bn | at 2022-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥1.9bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.5bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.7bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.7bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.4bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥1.2bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥3.1bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.7bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥4.2bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.9bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥806m | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥619m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥622m | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥2.8bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥545m | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥29.66 | 2025-04-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥74.34 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥55.77 | 2023-04-01 → 2024-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35.99 | 2022-04-01 → 2023-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥14.47 | 2021-04-01 → 2022-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥647.33 | at 2026-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥624.48 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥543.6 | at 2024-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥465.86 | at 2023-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥415.13 | at 2022-03-31v | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 52.4% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 48.0% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.1% | at 2024-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.8% | at 2023-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.1% | at 2022-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 4.7% | 2025-04-01 → 2026-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.7% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.1% | 2023-04-01 → 2024-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.2% | 2022-04-01 → 2023-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 3.6% | 2021-04-01 → 2022-03-31v | Cons. | Rate of return on equity (5-year summary) |
| Employees | 468 | at 2026-03-31 | Cons. | Number of employees |
| Employees | 727 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 720 | at 2024-03-31v | Cons. | Number of employees |
| Employees | 698 | at 2023-03-31v | Cons. | Number of employees |
| Employees | 691 | at 2022-03-31v | Cons. | Number of employees |
| Revenue | ¥17.5bn | 2025-04-01 → 2026-03-31 | Standalone | Net sales |
| Revenue | ¥16.9bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥17.1bn | 2023-04-01 → 2024-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥16.0bn | 2022-04-01 → 2023-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥13.8bn | 2021-04-01 → 2022-03-31v | Standalone | Net sales (5-year summary) |
| Operating income | ¥536m | 2025-04-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | ¥466m | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | ¥728m | 2025-04-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥591m | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥931m | 2023-04-01 → 2024-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥677m | 2022-04-01 → 2023-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥242m | 2021-04-01 → 2022-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥720m | 2025-04-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥595m | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | ¥484m | 2025-04-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | ¥430m | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥760m | 2023-04-01 → 2024-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥514m | 2022-04-01 → 2023-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥177m | 2021-04-01 → 2022-03-31v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥17.3bn | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥18.0bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥18.7bn | at 2024-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥17.8bn | at 2023-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥17.4bn | at 2022-03-31v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥8.1bn | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥9.3bn | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥9.2bn | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥8.7bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥8.3bn | at 2024-03-31v | Standalone | Net assets |
| Net assets / equity | ¥7.5bn | at 2023-03-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥7.0bn | at 2022-03-31v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.4bn | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥2.4bn | at 2025-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥28.45 | 2025-04-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥25.33 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥44.7 | 2023-04-01 → 2024-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥30.21 | 2022-04-01 → 2023-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥10.43 | 2021-04-01 → 2022-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥5 | 2025-04-01 → 2026-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥5 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥5 | 2023-04-01 → 2024-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥3 | 2022-04-01 → 2023-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥3 | 2021-04-01 → 2022-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥538.65 | at 2026-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥510.11 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥489.51 | at 2024-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥440.3 | at 2023-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥411.58 | at 2022-03-31v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 53.0% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 48.3% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.5% | at 2024-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.1% | at 2023-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.2% | at 2022-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 5.4% | 2025-04-01 → 2026-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.1% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.6% | 2023-04-01 → 2024-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.1% | 2022-04-01 → 2023-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 2.6% | 2021-04-01 → 2022-03-31v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 17,014,000 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 17,014,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 17,014,000 | at 2024-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 17,014,000 | at 2023-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 17,014,000 | at 2022-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 385 | at 2026-03-31 | Standalone | Number of employees |
| Employees | 387 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 373 | at 2024-03-31v | Standalone | Number of employees |
| Employees | 389 | at 2023-03-31v | Standalone | Number of employees |
| Employees | 398 | at 2022-03-31v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 70
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2026-03-31 | −¥43m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2026-03-31 | −¥43m |
| Reconciling Itemsreconciling | segment assets | at 2026-03-31 | ¥2.9bn |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2026-03-31 | ¥0 |
| Injection Molding Business In Chinareportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥11m |
| Injection Molding Business In Chinareportable segment | employees | at 2026-03-31 | 28 pure |
| Injection Molding Business In Chinareportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥594m |
| Injection Molding Business In Chinareportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥551m |
| Injection Molding Business In Chinareportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥42m |
| Injection Molding Business In Chinareportable segment | segment assets | at 2026-03-31 | ¥675m |
| Injection Molding Business In Chinareportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥7m |
| Injection Molding Business In Japanreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥968m |
| Injection Molding Business In Japanreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥2.0bn |
| Injection Molding Business In Japanreportable segment | employees | at 2026-03-31 | 417 pure |
| Injection Molding Business In Japanreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥21.0bn |
| Injection Molding Business In Japanreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥21.0bn |
| Injection Molding Business In Japanreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥0 |
| Injection Molding Business In Japanreportable segment | segment assets | at 2026-03-31 | ¥17.2bn |
| Injection Molding Business In Japanreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥481m |
| Real Estate Businessreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥6m |
| Real Estate Businessreportable segment | employees | at 2026-03-31 | 1 pure |
| Real Estate Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥284m |
| Real Estate Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥284m |
| Real Estate Businessreportable segment | segment assets | at 2026-03-31 | ¥251m |
| Real Estate Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥234m |
| —segment total | capex | 2025-04-01 → 2026-03-31 | ¥968m |
| —segment total | depreciation | 2025-04-01 → 2026-03-31 | ¥2.0bn |
| —segment total | revenue | 2025-04-01 → 2026-03-31 | ¥21.9bn |
| —segment total | revenue external | 2025-04-01 → 2026-03-31 | ¥21.9bn |
| —segment total | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥43m |
| —segment total | segment assets | at 2026-03-31 | ¥18.1bn |
| —segment total | segment profit | 2025-04-01 → 2026-03-31 | ¥723m |
| Otherother segments | capex | 2024-04-01 → 2025-03-31 | ¥974m |
| Otherother segments | depreciation | 2024-04-01 → 2025-03-31 | ¥621m |
| Otherother segments | revenue | 2024-04-01 → 2025-03-31 | ¥7.2bn |
| Otherother segments | revenue external | 2024-04-01 → 2025-03-31 | ¥7.2bn |
| Otherother segments | segment profit | 2024-04-01 → 2025-03-31 | ¥433m |
| Reconciling Itemsreconciling | depreciation | 2024-04-01 → 2025-03-31 | −¥20m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2025-03-31 | −¥47m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2025-03-31 | −¥47m |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | ¥3.2bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | ¥21m |
| Injection Molding Business In Chinareportable segment | capex | 2024-04-01 → 2025-03-31 | ¥2m |
| Injection Molding Business In Chinareportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥11m |
| Injection Molding Business In Chinareportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥538m |
| Injection Molding Business In Chinareportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥533m |
| Injection Molding Business In Chinareportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥5m |
| Injection Molding Business In Chinareportable segment | segment assets | at 2025-03-31 | ¥613m |
| Injection Molding Business In Chinareportable segment | segment profit | 2024-04-01 → 2025-03-31 | −¥28m |
| Injection Molding Business In Japanreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥2.3bn |
| Injection Molding Business In Japanreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥1.6bn |
| Injection Molding Business In Japanreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥19.9bn |
| Injection Molding Business In Japanreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥19.8bn |
| Injection Molding Business In Japanreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥42m |
| Injection Molding Business In Japanreportable segment | segment assets | at 2025-03-31 | ¥18.1bn |
| Injection Molding Business In Japanreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥239m |
| Real Estate Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥6m |
| Real Estate Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥284m |
| Real Estate Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥284m |
| Real Estate Businessreportable segment | segment assets | at 2025-03-31 | ¥257m |
| Real Estate Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥248m |
| —segment total | capex | 2024-04-01 → 2025-03-31 | ¥2.3bn |
| —segment total | depreciation | 2024-04-01 → 2025-03-31 | ¥1.6bn |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥20.7bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥20.6bn |
| —segment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥47m |
| —segment total | segment assets | at 2025-03-31 | ¥18.9bn |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥459m |
| Injection Molding Business In Japanreportable segment | employees | at 2026-03-31 | 362 pure |
| Real Estate Businessreportable segment | employees | at 2026-03-31 | 1 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,480
| Item | Context | Value | Unit |
|---|---|---|---|
| Percentage of shareholdings foreign individuals | CurrentYearInstant_OrdinaryShareMember | 0.0015 | |
| Percentage of shareholdings individuals and others | CurrentYearInstant_OrdinaryShareMember | 0.2678 | |
| Number of shares held | CurrentYearInstant_No1MajorShareholdersMember | 5722000 | |
| Shareholding ratio | CurrentYearInstant_No1MajorShareholdersMember | 0.3363 | |
| Number of shares held | CurrentYearInstant_No2MajorShareholdersMember | 2352000 | |
| Shareholding ratio | CurrentYearInstant_No2MajorShareholdersMember | 0.1382 | |
| Number of shares held | CurrentYearInstant_No3MajorShareholdersMember | 890000 | |
| Shareholding ratio | CurrentYearInstant_No3MajorShareholdersMember | 0.0523 | |
| Number of shares held | CurrentYearInstant_No4MajorShareholdersMember | 520000 | |
| Shareholding ratio | CurrentYearInstant_No4MajorShareholdersMember | 0.0305 | |
| Number of shares held | CurrentYearInstant_No5MajorShareholdersMember | 471000 | |
| Shareholding ratio | CurrentYearInstant_No5MajorShareholdersMember | 0.0277 | |
| Number of shares held | CurrentYearInstant_No6MajorShareholdersMember | 365000 | |
| Shareholding ratio | CurrentYearInstant_No6MajorShareholdersMember | 0.0214 | |
| Number of shares held | CurrentYearInstant_No7MajorShareholdersMember | 252000 | |
| Shareholding ratio | CurrentYearInstant_No7MajorShareholdersMember | 0.0148 | |
| Number of shares held | CurrentYearInstant_No8MajorShareholdersMember | 250000 | |
| Shareholding ratio | CurrentYearInstant_No8MajorShareholdersMember | 0.0146 | |
| Number of shares held | CurrentYearInstant_No9MajorShareholdersMember | 222000 | |
| Shareholding ratio | CurrentYearInstant_No9MajorShareholdersMember | 0.0130 | |
| Number of shares held | CurrentYearInstant_No10MajorShareholdersMember | 220000 | |
| Shareholding ratio | CurrentYearInstant_No10MajorShareholdersMember | 0.0129 | |
| Number of shares held | CurrentYearInstant | 11265000 | |
| Shareholding ratio | CurrentYearInstant | 0.6621 | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 17006400 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 170064 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesLessThanOneUnitMember | 7600 | |
| Number of shares issued shares voting rights | CurrentYearInstant | 17014000 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant | 170064 | |
| Total amount of dividends dividends of surplus | FilingDateInstant_Row1Member | 85000000 | JPY |
| Dividend per share dividends of surplus | FilingDateInstant_Row1Member | 5 | |
| Number of male directors and other officers | FilingDateInstant | 10 | |
| Number of female directors and other officers | FilingDateInstant | － | |
| Ratio of female directors and other officers | FilingDateInstant | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01813-000FujimotoKensukeMember | 11000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01813-000TadahikoIshikawaMember | 222000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01813-000MisaoSugiyamaMember | 4000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01813-000IsamuKishidaMember | 3000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01813-000KaoruGotoMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01813-000RyuichiKomatsuzakiMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01813-000SusumuKandaMember | 1000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01813-000HiroyukiSakamotoMember | 1000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01813-000TakashiTsudaMember | 33000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01813-000HitoshiMouriMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant | 276000 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |